Similar articles for PMID: 16606670

Year	Number of Results
1995	1
2000	1
2001	2
2002	4
2003	5
2004	8
2005	6
2006	9
2007	14
2008	13
2009	17
2010	34
2011	25
2012	6
2013	13
2014	15
2015	1
2016	2
2017	7
2018	5
2019	6
2020	9
2021	16
2022	27
2023	2
2024	0

1

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH. Keir ME, et al. J Exp Med. 2006 Apr 17;203(4):883-95. doi: 10.1084/jem.20051776. Epub 2006 Apr 10. J Exp Med. 2006. PMID: 16606670 Free PMC article.

2

The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.

Paterson AM, Brown KE, Keir ME, Vanguri VK, Riella LV, Chandraker A, Sayegh MH, Blazar BR, Freeman GJ, Sharpe AH. Paterson AM, et al. J Immunol. 2011 Aug 1;187(3):1097-105. doi: 10.4049/jimmunol.1003496. Epub 2011 Jun 22. J Immunol. 2011. PMID: 21697456 Free PMC article.

3

Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.

Wang CJ, Chou FC, Chu CH, Wu JC, Lin SH, Chang DM, Sytwu HK. Wang CJ, et al. Diabetes. 2008 Jul;57(7):1861-9. doi: 10.2337/db07-1260. Epub 2008 Apr 16. Diabetes. 2008. PMID: 18420489 Free PMC article.

4

Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles.

Menke J, Lucas JA, Zeller GC, Keir ME, Huang XR, Tsuboi N, Mayadas TN, Lan HY, Sharpe AH, Kelley VR. Menke J, et al. J Immunol. 2007 Dec 1;179(11):7466-77. doi: 10.4049/jimmunol.179.11.7466. J Immunol. 2007. PMID: 18025191

5

Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.

Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H Jr, Sayegh MH, Najafian N. Ito T, et al. J Immunol. 2005 Jun 1;174(11):6648-56. doi: 10.4049/jimmunol.174.11.6648. J Immunol. 2005. PMID: 15905503

6

The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival.

Shen L, Jin Y, Freeman GJ, Sharpe AH, Dana MR. Shen L, et al. J Immunol. 2007 Sep 15;179(6):3672-9. doi: 10.4049/jimmunol.179.6.3672. J Immunol. 2007. PMID: 17785803

7

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.

Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR, Greenfield EA, Freeman GJ. Brown JA, et al. J Immunol. 2003 Feb 1;170(3):1257-66. doi: 10.4049/jimmunol.170.3.1257. J Immunol. 2003. PMID: 12538684

8

Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart.

Grabie N, Gotsman I, DaCosta R, Pang H, Stavrakis G, Butte MJ, Keir ME, Freeman GJ, Sharpe AH, Lichtman AH. Grabie N, et al. Circulation. 2007 Oct 30;116(18):2062-71. doi: 10.1161/CIRCULATIONAHA.107.709360. Epub 2007 Oct 15. Circulation. 2007. PMID: 17938288

9

Expression of programmed death 1 ligands by murine T cells and APC.

Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M, Yagita H. Yamazaki T, et al. J Immunol. 2002 Nov 15;169(10):5538-45. doi: 10.4049/jimmunol.169.10.5538. J Immunol. 2002. PMID: 12421930

10

LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.

Lucas CL, Workman CJ, Beyaz S, LoCascio S, Zhao G, Vignali DA, Sykes M. Lucas CL, et al. Blood. 2011 May 19;117(20):5532-40. doi: 10.1182/blood-2010-11-318675. Epub 2011 Mar 21. Blood. 2011. PMID: 21422469 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

227 results

Results by year